TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 34 filers reported holding TENAX THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $123,000 | -12.8% | 62,970 | +3.6% | 0.00% | – |
| Q3 2016 | $141,000 | -9.6% | 60,788 | +0.1% | 0.00% | – |
| Q2 2016 | $156,000 | +22.8% | 60,747 | -1.7% | 0.00% | – |
| Q1 2016 | $127,000 | -41.7% | 61,768 | -7.1% | 0.00% | – |
| Q4 2015 | $218,000 | +14.1% | 66,464 | +4.3% | 0.00% | – |
| Q3 2015 | $191,000 | -20.7% | 63,701 | -2.6% | 0.00% | – |
| Q2 2015 | $241,000 | +14.2% | 65,387 | +1.2% | 0.00% | – |
| Q1 2015 | $211,000 | -20.4% | 64,627 | -6.4% | 0.00% | – |
| Q4 2014 | $265,000 | -5.7% | 69,011 | -3.4% | 0.00% | – |
| Q3 2014 | $281,000 | – | 71,416 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,108,593 | $4,091,000 | 1.60% |
| RA Capital Management | 2,670,300 | $9,853,000 | 0.99% |
| Opaleye Management Inc. | 635,000 | $2,343,000 | 0.93% |
| Broadfin Capital, LLC | 1,968,631 | $7,264,000 | 0.39% |
| SABBY MANAGEMENT, LLC | 2,686,247 | $9,913,000 | 0.36% |
| Verition Fund Management LLC | 39,175 | $145,000 | 0.02% |
| FIRST NEW YORK SECURITIES LLC /NY | 8,000 | $29,520,000 | 0.02% |
| FNY Managed Accounts LLC | 3,000 | $11,070,000 | 0.01% |
| Baker Brothers Advisors | 355,348 | $1,311,000 | 0.01% |
| Karp Capital Management Corp | 700 | $3,000 | 0.00% |